|
|
Christian Weyer, Clifton Bogardus, David M. Mott, Richard E. Pratley
J Clin Invest. 1999;
104(6):787
doi:10.1172/JCI7231
Abstract |
Full text
| PDF

T
he pathogenesis of type 2 diabetes involves abnormalities in insulin action, insulin secretion, and endogenous glucose output (EGO). However, the sequence with which these abnormalities develop and their relative contributions to the deterioration in glucose tolerance remain unclear in the absence of a detailed longitudinal study. We measured insulin action, insulin secretion, and EGO longitudinally in 17 Pima Indians, in whom glucose tolerance deteriorated from normal (NGT) to impaired (IGT) to diabetic over 5.1 ± 1.4 years. Transition from NGT to IGT was associated with an increase in body weight, a decline in insulin-stimulated glucose disposal, and a decline in the acute insulin secretory response (AIR) to intravenous glucose, but no change in EGO. Progression from IGT to diabetes was accompanied by a further increase in body weight, further decreases in insulin-stimulated glucose disposal and AIR, and an increase in basal EGO. Thirty-one subjects who retained NGT over a similar period also gained weight, but their AIR increased with decreasing insulin-stimulated glucose disposal. Thus, defects in insulin secretion and insulin action occur early in the pathogenesis of diabetes. Intervention to prevent diabetes should target both abnormalities.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(330)
| Title and authors |
Publication |
Year |
β-cell Dysfunction in Adolescents and Adults with Newly Diagnosed Type 2 Diabetes Mellitus
Deborah A. Elder, Patricia M. Herbers, Tammy Weis, Debra Standiford, Jessica G. Woo, David A. D’Alessio
|
The Journal of Pediatrics
|
2012 |
Effects of training on body composition, blood lipids, and glucose homeostasis assessed by the homeostasis model assessment
M. Eizadi, G. Bagheri, J.M. Kasparast, F. Zahedmanesh, Z. Afsharmand
|
Science & Sports
|
2012 |
Metabolic effects of high-dose prednisolone treatment in early rheumatoid arthritis: Balance between diabetogenic effects and inflammation reduction
Debby den Uyl, Daniel H. van Raalte, Michael T. Nurmohamed, Willem F. Lems, Johannes W. J. Bijlsma, Jos N. Hoes, Ben A. C. Dijkmans, Michaela Diamant
|
Arthritis Rheum
|
2012 |
β-Cell Dysfunction and the Onset of Type 2 Diabetes
Ilene Fennoy
|
The Journal of Pediatrics
|
2012 |
Aging Does Not Reduce Heat Shock Protein 70 in the Absence of Chronic Insulin Resistance
K. Kavanagh, A. T. Wylie, T. J. Chavanne, M. J. Jorgensen, V. S. Voruganti, A. G. Comuzzie, J. R. Kaplan, C. E. McCall, S. B. Kritchevsky
|
j gerontol med sci
|
2012 |
Simultaneous Measurement of Insulin Sensitivity, Insulin Secretion, and the Disposition Index in Conscious Unhandled Mice
Laura C. Alonso, Yoshio Watanabe, Darko Stefanovski, Euhan J. Lee, Srikanth Singamsetty, Lia C. Romano, Baobo Zou, Adolfo Garcia-Ocaña, Richard N. Bergman, Christopher P. O'Donnell
|
Obesity
|
2012 |
Type 2 diabetes in pediatrics and adults: Thoughts from a clinical pharmacology perspective
Jayabharathi Vaidyanathan, Sally Choe, Chandrahas G. Sahajwalla
|
J. Pharm. Sci.
|
2012 |
Metabolic Syndrome
Taly Meas, Pierre-Jean Guillausseau
|
Metabolic Syndrome
|
2011 |
Dynamics of insulin secretion and the clinical implications for obesity and diabetes
Susumu Seino, Tadao Shibasaki, Kohtaro Minami
|
J. Clin. Invest.
|
2011 |
Hormonal Regulation of Hepatic Glucose Production in Health and Disease
Hua V. Lin, Domenico Accili
|
Cell Metabolism
|
2011 |
|